In the latest trading session, 2.45 million Hoth Therapeutics Inc (NASDAQ:HOTH) shares changed hands as the company’s beta touched 0.61. With the company’s most recent per share price at $1.51 changing hands around $0.02 or 1.38% at last look, the market valuation stands at $6.57M. HOTH’s current price is a discount, trading about -184.77% off its 52-week high of $4.30. The share price had its 52-week low at $0.99, which suggests the last value was 34.44% up since then. When we look at Hoth Therapeutics Inc’s average trading volume, we note the 10-day average is 2.19 million shares, with the 3-month average coming to 565.75K.
Hoth Therapeutics Inc (NASDAQ:HOTH) trade information
Instantly HOTH is in green as seen in intraday trades today. With action 3.47%, the performance over the past five days has been green. The jump to weekly highs of 1.6500 added 1.38% to the stock’s daily price. The company’s shares are showing year-to-date upside of 4.90%, with the 5-day performance at 3.47% in the green. However, in the 30-day time frame, Hoth Therapeutics Inc (NASDAQ:HOTH) is 18.94% up. Looking at the short shares, we see there were 76360.0 shares sold at short interest cover period of 1.82 days.
Hoth Therapeutics Inc (HOTH) estimates and forecasts
Data shows that the Hoth Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -2.54% over the past 6 months, a 74.42% in annual growth rate that is considerably higher than the industry average of 12.60%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2024 revenue estimates. The rating firms predict current quarter revenue for Hoth Therapeutics Inc will rise 82.20%, while the growth in revenue is estimated to hit 38.60% for the next quarter.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -25.04%. The 2024 estimates are for Hoth Therapeutics Inc earnings to increase by 24.55%.
Hoth Therapeutics Inc (NASDAQ:HOTH)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.93% of Hoth Therapeutics Inc shares while 7.07% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.14%. There are 7.07% institutions holding the Hoth Therapeutics Inc stock share, with Geode Capital Management, LLC the top institutional holder. As of Jun 29, 2023, the company held 0.74% of the shares, roughly 24340.0 HOTH shares worth $73020.0.
Citadel Advisors Llc holds the second largest percentage of outstanding shares, with 0.62% or 20428.0 shares worth $61284.0 as of Jun 29, 2023.
Among Mutual Funds, the top two as of Jun 29, 2023 were Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. With 12232.0 shares estimated at $36696.0 under it, the former controlled 0.37% of total outstanding shares. On the other hand, Fidelity Extended Market Index Fund held about 0.08% of the shares, roughly 2593.0 shares worth around $4122.0.
